Publication | Open Access
Effect of miR-133b on progression and cisplatin resistance of triple-negative breast cancer through FGFR1-Wnt-β-catenin axis.
13
Citations
31
References
2021
Year
To sum up, miR-133b can inhibit the growth and DDP resistance of TNBC cells by targeting FGFR1 and inactivating the Wnt-β-catenin pathway.
| Year | Citations | |
|---|---|---|
Page 1
Page 1